ZB2-16962-16735
3 vaccinations
10 coded responses
22 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 009 / PR
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Registered in v-safe
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-19
Survey response — day 7, dose 2MedDRA: Fatigue, Headache, Immediate post-injection reaction, Nausea, Pyrexia — Feeling: Good · Site: PainFree text: Mild fever, Headache, nausea, tiredness 12-48 hrs post both vaccine dosesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 35, dose 2MedDRA: Abdominal discomfort, Arthralgia, Condition aggravated, Dizziness, Epistaxis, Heavy menstrual bleeding, Hypoaesthesia, Pain in extremity, Paraesthesia, Pre-existing disease — Feeling: GoodFree text: I have fibromyalgia: Hip and leg pain with tingling/numbness returned and worsening of shoulder pain despite adherence to gabapentin. Dizziness also experienced as on/off. Epistaxis, GI discomfort,heavy menstrual bleeding but may be due to celebrexMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — day 42, dose 2MedDRA: Abdominal discomfort, Arthralgia, Dizziness, Epistaxis, Gingival bleeding, Paraesthesia — Feeling: FairFree text: Joint pain, Gi discomfort, epistaxis, gum bleeding, tingling/numbness in arms and legs, dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — 3 months, dose 2MedDRA: Epistaxis, Heavy menstrual bleeding, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Weekly episode of epistaxis continue . Monthly heavy menstrual bleeding continue. · Healthcare visit (other): Pending appointment for medical evaluationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-17
Survey response — 6 months, dose 2MedDRA: Epistaxis, Heavy menstrual bleeding — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ocasional Nosebleeds and heavy menstrual bleeding continueMedDRA releases: 2024-11 · check-in free text available
-
2021-07-17
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-28
-
2022-01-14
Dose 3 — Pfizer-BioNTech
- 2022-01-14
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-16
Survey response — days 1–6 daily, dose 3MedDRA: Diarrhoea — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Loose stoolsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-19
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Site: Pain · Joint painsFree text: Arm pit pain in same arm where I got the shotMedDRA releases: 2024-11 · check-in free text available
-
2022-01-20
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Axillary pain — Feeling: Fair · Site: Pain · Joint painsFree text: Shoulder an axila painMedDRA releases: 2024-11 · check-in free text available
- 2022-01-23
-
2022-01-28
Survey response — day 14, dose 3MedDRA: Cardiac aneurysm — Feeling: GoodFree text: Interatrial aneurysmMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Survey response — day 21, dose 3MedDRA: Arthralgia, Back pain — Feeling: GoodFree text: Hip and back painMedDRA releases: 2024-11 · check-in free text available
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-04-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-15 | Unsuccessful | |
| 2021-07-17 | Unsuccessful |
Free text
Release 2 — day 7, dose 2
Systemic reaction (other): Mild fever, Headache, nausea, tiredness 12-48 hrs post both vaccine doses
Release 4 — day 35, dose 2
Symptoms: I have fibromyalgia: Hip and leg pain with tingling/numbness returned and worsening of shoulder pain despite adherence to gabapentin. Dizziness also experienced as on/off. Epistaxis, GI discomfort,heavy menstrual bleeding but may be due to celebrex cut off by CDC
Release 4 — day 42, dose 2
Symptoms: Joint pain, Gi discomfort, epistaxis, gum bleeding, tingling/numbness in arms and legs, dizziness
Release 7 — 3 months, dose 2
Symptoms: Weekly episode of epistaxis continue . Monthly heavy menstrual bleeding continue.
Healthcare visit (other): Pending appointment for medical evaluation
Release 9 — 6 months, dose 2
Symptoms: Ocasional Nosebleeds and heavy menstrual bleeding continue
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Loose stools
Systemic reaction (other): Arm pit pain in same arm where I got the shot
Systemic reaction (other): Shoulder an axila pain
Release 11 — day 14, dose 3
Symptoms: Interatrial aneurysm
Release 11 — day 21, dose 3
Symptoms: Hip and back pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Cardiac aneurysm | · | · | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Epistaxis | ✓ | ✓ | ✓ |
| SD | Gingival bleeding | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hypoaesthesia | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Diarrhoea | · | · | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release